Europe's Counterfeit Cigarette Crisis: A Problem Defined by Its Prime Suspect

📊 Key Data
  • 10% of EU cigarette market is now illicit (2025), with 41.8 billion counterfeit cigarettes consumed annually.
  • €16.7 billion in lost tax revenues for EU member states.
  • 44% of illicit cigarettes are counterfeits, up 20% in one year.
🎯 Expert Consensus

Experts agree the illicit cigarette crisis in Europe is worsening due to shifting criminal tactics and policy challenges, but the industry-funded data warrants independent verification.

19 days ago
Europe's Counterfeit Cigarette Crisis: A Problem Defined by Its Prime Suspect

Europe's Counterfeit Cigarette Crisis: A Problem Defined by Its Prime Suspect

STAMFORD, CT – June 03, 2026 – The European Union is facing a shadow pandemic. According to a new study, the consumption of illicit cigarettes surged past 10% of the total market in 2025, a threshold not crossed in over a decade. This underground economy, now accounting for 41.8 billion cigarettes annually, is siphoning an estimated €16.7 billion in tax revenues from member state coffers—a figure that could fund significant public services.

The report, the 20th of its kind conducted by KPMG, was commissioned and publicized by Philip Morris International (PMI), one of the world's largest tobacco producers. Its findings paint a stark picture: the illicit market is not only growing but transforming. The primary engine of this growth is no longer cross-border smuggling of known brands but a boom in counterfeit cigarettes manufactured directly within or near the EU's high-value markets. Yet, as with any crisis, the crucial question is not just what the problem is, but who gets to define it—and the proposed solution.

The New Anatomy of a Black Market

For years, the story of illicit tobacco in Europe was one of contraband flowing from east to west. Organized crime exploited tax differentials, smuggling legally produced cigarettes from low-tax jurisdictions into high-tax ones. The new report argues this model is being fundamentally disrupted. The real threat, it contends, is now "Made in EU" fakes.

Counterfeit cigarettes, which are illegally manufactured knock-offs of trademarked brands, now constitute 44% of all illicit consumption in the EU, reaching 18.3 billion units in 2025—a staggering 20% increase in a single year. This shift represents a strategic evolution by criminal networks. By moving production closer to end consumers in Western Europe, they create faster, more agile, and harder-to-trace supply chains. Countries like France, Belgium, and the Netherlands have reportedly become central hubs not just for consumption but for illicit production and distribution.

This operational shift is not just an industry talking point; it is a reality acknowledged by law enforcement. Agencies like EUROPOL have noted the trend towards illegal manufacturing within the EU, a development that complicates enforcement efforts that were previously focused on border control. Dismantling a network of scattered, clandestine factories requires a different set of resources and intelligence capabilities than interdicting shipping containers and trucks. The result is a more resilient and localized criminal enterprise that operates with what PMI's Group Chief Legal Officer, Yann Guérin, calls "speed, scale, and impunity."

France stands out as the epicenter of this crisis, with the report claiming an illicit market share of 41.4%, meaning more than two in every five cigarettes consumed are from the black market. Of these, nearly half are counterfeits. The Netherlands and Belgium also post alarming figures, with illicit shares soaring above 22% and 25% respectively.

The Policy Blame Game

According to Philip Morris International, the explanation for this surge is clear: misguided public policy. The company draws a sharp contrast between member states. On one side are countries like France and the Netherlands, which have implemented steep tax hikes and product restrictions. These markets, the report argues, are seeing illicit trade spiral out of control.

"Countries that promote excessive tax increases, or, even worse, product bans... see illicit trends worsening, public tax collection suffers, consumers gain access to uncontrolled products, and crime thrives," stated Massimo Andolina, PMI's President for the Europe Region.

On the other side are countries like Greece and war-torn Ukraine, which have reportedly seen declines in illicit consumption. PMI attributes this success to a "balanced policy mix" of predictable fiscal approaches and consistent enforcement. "The lesson we derive... is that not one single lever solves the problem," Andolina added. "It is that a well-coordinated set of measures does."

The argument that high taxes can fuel a black market is not without merit; it's a basic economic principle that EUROPOL itself has acknowledged as a contributing factor. However, when the argument comes from a tobacco giant whose primary products are the target of those same taxes, it warrants deeper scrutiny. The report effectively serves as a powerful lobbying tool, providing seemingly objective data to argue that the very public health measures designed to curb smoking are, in fact, creating a more dangerous and chaotic market.

The Messenger Under Scrutiny

This brings us to the central challenge of analyzing the illicit trade problem: the data itself. The "Project SUN" study, as KPMG's annual report is known, has long been a subject of intense criticism from the public health community and independent research bodies. Critics argue that these are not transparent academic studies but "business documents" born from a private contract.

"The methodology has been questioned for years," noted one public health expert familiar with the reports. "The reliance on Empty Pack Surveys, where the tobacco companies themselves are involved in identifying what's counterfeit, creates an obvious potential for bias. The sampling methods are often not fully transparent, and there's a risk of over-representing areas known for high illicit activity."

Indeed, KPMG's own reports contain disclaimers clarifying that they assume no responsibility to any party other than their client, PMI, and that the findings cannot be relied upon for any other purpose. This crucial caveat is often lost in the headline-grabbing figures. Independent academic reviews have repeatedly found that industry-funded estimates of illicit trade tend to be significantly higher than those produced by non-industry sources.

This context is inseparable from PMI's broader corporate transformation. The company is investing billions to pivot towards a "smoke-free future" built on heated tobacco, e-vapor, and nicotine pouches. By framing the illicit cigarette crisis as a failure of "extreme" regulation, PMI not only defends its legacy combustible business from further taxation but also builds a case for its preferred "evidence-based, risk-proportionate" regulatory model for its new products. The underlying message is that if governments regulate new nicotine products too harshly, they will simply create a new black market, a point subtly reinforced by the report's finding of "not eligible for sale" nicotine pouches in markets where they are banned.

A Threat Beyond Revenue

While the exact scale of the illicit market may be debated, the public health threat it poses is undeniable. Counterfeit cigarettes are produced in unregulated conditions with no quality control. The World Health Organization has long warned that such products can contain higher levels of tar and nicotine, as well as a cocktail of contaminants ranging from heavy metals to plastic and dust. Consumers, often believing they are buying a legitimate brand at a discount, are unknowingly exposing themselves to amplified risks.

The €16.7 billion in lost taxes is a tangible loss to European society, but the erosion of public health standards and the empowerment of organized crime networks represent deeper, more corrosive costs. The illicit trade undermines decades of public health policy aimed at reducing smoking prevalence by making cheaper, and potentially more dangerous, products readily available, particularly to vulnerable young people and low-income groups.

The situation leaves European policymakers in a difficult position. They face a genuine and growing threat from sophisticated criminal networks that are adapting their tactics with alarming speed. Yet the primary narrator of this crisis is a corporate entity with a vested interest in a particular policy outcome. Crafting an effective response requires separating the verifiable facts of the illicit market's evolution from the self-serving narrative used to frame them, a task that becomes harder when the lines between data and advocacy are so deliberately blurred.

Sector: Healthcare & Life Sciences CPG & FMCG
Theme: Trade Wars & Tariffs
Event: Policy Change Product Launch
Product: Pharmaceuticals & Therapeutics
Metric: Revenue
UAID: 33340